We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
19 hedge funds and large institutions have $9.98M invested in Arcturus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more capital invested
Capital invested by funds: $5.29M → $9.98M (+$4.69M)
2.64% more ownership
Funds ownership: 10.94% → 13.58% (+2.6%)
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
5
Calls
$82K
Puts
–
Net Calls
+$82K
Net Calls Change
+$80K
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$201K |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$131K |
| 3 |
Morgan Stanley
New York
|
-$7.69K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7K |
| 5 |
BlackRock
New York
|
-$6.66K |
